-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vj+9RiQQq1b90+1nMoPTfC8A32m/2PjVzyHxyJDQVhpLE/VRKOdkHXRJsafwF6Ih kKc/F3vBpZYxTY1X6L1i9Q== 0001104659-08-036220.txt : 20080528 0001104659-08-036220.hdr.sgml : 20080528 20080528160651 ACCESSION NUMBER: 0001104659-08-036220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080523 FILED AS OF DATE: 20080528 DATE AS OF CHANGE: 20080528 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCIELE PHARMA, INC. CENTRAL INDEX KEY: 0001106773 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582004779 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: FIVE CONCOURSE PARKWAY STREET 2: SUITE 1800 CITY: ATALANTA STATE: GA ZIP: 30328 BUSINESS PHONE: 678-341-1436 MAIL ADDRESS: STREET 1: FIVE CONCOURSE PARKWAY STREET 2: SUITE 1800 CITY: ATALANTA STATE: GA ZIP: 30328 FORMER COMPANY: FORMER CONFORMED NAME: FIRST HORIZON PHARMACEUTICAL CORP DATE OF NAME CHANGE: 20000214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAXE JON S CENTRAL INDEX KEY: 0001114914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30123 FILM NUMBER: 08863654 BUSINESS ADDRESS: BUSINESS PHONE: 7704429707 MAIL ADDRESS: STREET 1: FIRST HORIZON PHARMACEUTICAL CORP STREET 2: 660 HEMBREE PKWY STE 106 CITY: ROSWELL STATE: GA ZIP: 30076 4 1 a4.xml 4 X0202 4 2008-05-23 0 0001106773 SCIELE PHARMA, INC. SCRX 0001114914 SAXE JON S C/O SCIELE PHARMA, INC. FIVE CONCOURSE PARKWAY, SUITE 1800 ATLANTA GA 30328 1 0 0 0 Common Stock 2008-05-23 4 M 0 3750 A 22250 D Common Stock 2008-05-23 4 S 0 3750 21.08 D 18500 D Stock Option Granted 2001-05-25 18.917 2008-05-23 4 M 0 3750 0 D 2005-05-25 2008-05-25 Common Stock 3750 0 D Acquired on exercise of stock options reported in Table II of this Form 4. Price paid on acquisition equals exercise price of shares underlying stock option exercise reported in Table II of this Form 4. Michael Milligan by power of attorney for Jon Saxe 2008-05-28 -----END PRIVACY-ENHANCED MESSAGE-----